Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nutri-Strips Sleep A.S.A.P. is an oral thin-film dietary supplement sleep aid developed by Sera Labs using CURE Pharmaceutical's RAD3 rapid-activation delivery technology. The product is designed to dissolve on the tongue without water and is marketed to help users fall asleep and stay asleep. It is a multi-ingredient small molecule nutraceutical formulation containing melatonin, gamma-aminobutyric acid, l-theanine, vitamin B6, and beta-caryophyllene. Its intended sleep-promoting effect is based on the combined physiologic activities of these ingredients, primarily melatonin-mediated regulation of circadian sleep signaling together with calming or relaxation-associated nutraceutical components, rather than a single defined pharmaceutical target. It is marketed as a non-habit-forming, drug-free sleep support product rather than an FDA-approved therapeutic.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nutri-Strips Sleep A.S.A.P..